DarioHealth (DRIO) Cash from Financing Activities (2012 - 2025)

DarioHealth has reported Cash from Financing Activities for 14 years, with the latest figure at -$19000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities fell 100.1% year-over-year to -$19000.0; the trailing twelve-month figure through Dec 2025 stood at $24.3 million (down 36.9% YoY), and the FY2025 full-year result was $24.3 million, down 36.9% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at -$19000.0, down from $17.4 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $65.7 million in Q1 2021, with the low at -$1.4 million in Q1 2023.
• Historically, Cash from Financing Activities has averaged $14.9 million across 5 years, with a median of $12.1 million in 2025.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 42903.64% — and 2023, when it slumped 103.65%.
• DarioHealth's Cash from Financing Activities stood at $55000.0 in 2021, then jumped by 381.82% to $265000.0 in 2022, then decreased by 23.02% to $204000.0 in 2023, then soared by 8882.84% to $18.3 million in 2024, then slumped by 100.1% to -$19000.0 in 2025.
• The last three Cash from Financing Activities figures came in at -$19000.0 (Q4 2025), $17.4 million (Q3 2025), and $124000.0 (Q2 2025), per Business Quant data.